Búsqueda | Portal de Búsqueda de la BVS

1.

Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction.

Charrier, S; Ferrand, M; Zerbato, M; Précigout, G; Viornery, A; Bucher-Laurent, S; Benkhelifa-Ziyyat, S; Merten, O W; Perea, J; Galy, A.

Gene Ther ; 18(5): 479-87, 2011 May.

Artículo en Inglés | MEDLINE | ID: mdl-21160533

2.

IgG production in hybridoma batch culture: kinetics of IgG mRNA, cytoplasmic-, secreted- and membrane-bound antibody levels.

Leno, M; Merten, O W; Vuillier, F; Hache, J.

J Biotechnol ; 20(3): 301-11, 1991 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-1367575

3.

Comparison of different bioreactor systems for the production of high titer retroviral vectors.

Merten, O W; Cruz, P E; Rochette, C; Geny-Fiamma, C; Bouquet, C; Gonçalves, D; Danos, O; Carrondo, M J.

Biotechnol Prog ; 17(2): 326-35, 2001.

Artículo en Inglés | MEDLINE | ID: mdl-11312711

4.

Kinetic studies of cellular metabolic activity, specific IgG production rate, IgG mRNA stability and accumulation during hybridoma batch culture.

Leno, M; Merten, O W; Hache, J.

Enzyme Microb Technol ; 14(2): 135-40, 1992 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-1368396

5.

Production of influenza virus in cell cultures for vaccine preparation.

Merten, O W; Hannoun, C; Manuguerra, J C; Ventre, F; Petres, S.

Adv Exp Med Biol ; 397: 141-51, 1996.

Artículo en Inglés | MEDLINE | ID: mdl-8718593

6.

Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.

Merten, O W.

Dev Biol (Basel) ; 111: 233-57, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-12678248

7.

Large-scale production means for the manufacturing of lentiviral vectors.

Schweizer, M; Merten, O-W.

Curr Gene Ther ; 10(6): 474-86, 2010 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-21054245

8.

Relevance of an academic GMP Pan-European vector infra-structure (PEVI).

Cohen-Haguenauer, O; Creff, N; Cruz, P; Tunc, C; Aïuti, A; Baum, C; Bosch, F; Blomberg, P; Cichutek, K; Collins, M; Danos, O; Dehaut, F; Federspiel, M; Galun, E; Garritsen, H; Hauser, H; Hildebrandt, M; Klatzmann, D; Merten, O W; Montini, E; O'Brien, T; Panet, A; Rasooly, L; Scherman, D; Schmidt, M; Schweitzer, M; Tiberghien, P; Vandendriessche, T; Ziehr, H; Ylä-Herttuala, S; von Kalle, C; Gahrton, G; Carrondo, M.

Curr Gene Ther ; 10(6): 414-22, 2010 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-21054249

9.

New vaccine production technologies and their impact on the use of animals.

Pastoret, P P; Sitrin, R; Merten, O W; Vincent Falquet, J C; Schwanig, M; Welin, M; Hegger, I; Neeleman, R; van der Velden, T; Urital, A; Rene, S; Behr-Gross, M E; Smith, M; McArdle, J; Prior, S; Schmidt, C; Krell, T; Chevalier, M; Klein, H; Rosskopf-Streicher, U; Jaekel, C.

Dev Biol (Basel) ; 111: 219-20, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-12678245

10.

Retrovirus producer cell line metabolism: implications on viral productivity.

Coroadinha, A S; Alves, P M; Santos, S Sá; Cruz, P E; Merten, O-W; Carrondo, M J T.

Appl Microbiol Biotechnol ; 72(6): 1125-35, 2006 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-16598449

11.

Effect of medium sugar source on the production of retroviral vectors for gene therapy.

Coroadinha, A S; Ribeiro, J; Roldão, A; Cruz, P E; Alves, P M; Merten, O-W; Carrondo, M J T.

Biotechnol Bioeng ; 94(1): 24-36, 2006 May 05.

Artículo en Inglés | MEDLINE | ID: mdl-16514678

12.

Relationship between retroviral vector membrane and vector stability.

Carmo, M; Faria, T Q; Falk, H; Coroadinha, A S; Teixeira, M; Merten, O-W; Gény-Fiamma, C; Alves, P M; Danos, O; Panet, A; Carrondo, M J T; Cruz, P E.

J Gen Virol ; 87(Pt 5): 1349-1356, 2006 May.

Artículo en Inglés | MEDLINE | ID: mdl-16603538

13.

Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells.

Jenny, C; Toublanc, E; Danos, O; Merten, O-W.

Cytotechnology ; 49(1): 11-23, 2005 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-19003059

14.

Current issues in adeno-associated viral vector production.

Merten, O-W; Gény-Fiamma, C; Douar, A M.

Gene Ther ; 12 Suppl 1: S51-61, 2005 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-16231056

15.

State-of-the-art of the production of retroviral vectors.

Merten, O-W.

J Gene Med ; 6 Suppl 1: S105-24, 2004 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-14978755

16.

Virus contaminations of cell cultures - A biotechnological view.

Merten, O-W.

Cytotechnology ; 39(2): 91-116, 2002 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-19003296

17.

Safety issues of animal products used in serum-free media.

Merten, O W.

Dev Biol Stand ; 99: 167-80, 1999.

Artículo en Inglés | MEDLINE | ID: mdl-10404888

18.

Constructive improvement of the ultrasonic separation device ADI 1015.

Merten, O W.

Cytotechnology ; 34(1-2): 175-9, 2000 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-19003392

19.

Batch production and growth kinetics of hybridomas.

Merten, O W.

Cytotechnology ; 1(2): 113-21, 1988 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-22358562

20.

Application of sensors for the determination of physical and biochemical parameters in the fermentation of animal cells.

Merten, O W; Palfi, G E.

Dev Biol Stand ; 66: 111-42, 1987.

Artículo en Inglés | MEDLINE | ID: mdl-3556270

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction.

IgG production in hybridoma batch culture: kinetics of IgG mRNA, cytoplasmic-, secreted- and membrane-bound antibody levels.

Comparison of different bioreactor systems for the production of high titer retroviral vectors.

Kinetic studies of cellular metabolic activity, specific IgG production rate, IgG mRNA stability and accumulation during hybridoma batch culture.

Production of influenza virus in cell cultures for vaccine preparation.

Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.

Large-scale production means for the manufacturing of lentiviral vectors.

Relevance of an academic GMP Pan-European vector infra-structure (PEVI).

New vaccine production technologies and their impact on the use of animals.

Retrovirus producer cell line metabolism: implications on viral productivity.

Effect of medium sugar source on the production of retroviral vectors for gene therapy.

Relationship between retroviral vector membrane and vector stability.

Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells.

Current issues in adeno-associated viral vector production.

State-of-the-art of the production of retroviral vectors.

Virus contaminations of cell cultures - A biotechnological view.

Safety issues of animal products used in serum-free media.

Constructive improvement of the ultrasonic separation device ADI 1015.

Batch production and growth kinetics of hybridomas.

Application of sensors for the determination of physical and biochemical parameters in the fermentation of animal cells.